Preparation method and application of lactic acid bacteria biological membrane based on gel cell growth

Through the preparation method of lactic acid bacteria biofilm based on gel cell growth, the problems of low survival and difficulty in colonization of probiotics in the vaginal environment are solved, more efficient therapeutic effects and longer retention time are achieved, and dynamics are achieved through DNA nano-device Monitoring the microenvironment improves the predictability of treatment.

CN118909831APending Publication Date: 2024-11-08SHANGHAI TONGREN HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410946237.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-15
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

In the treatment of aerobic vaginitis, probiotics have low survival and difficulty in colonization in the vaginal environment, resulting in low treatment efficiency and high cost, and lack of effective dynamic evaluation methods, which affects the treatment effect.

Method used

Using the preparation method of lactic acid bacteria biofilm based on gel cell growth, vaginal epithelial cells are cultured into a complete sheet layer, combined with photoinitiator and polyethylene glycol diacrylate to form gelation buffer, and colloidization is formed by irradiation with ultraviolet lamp. The cell sheet was inoculated with plankton lactic acid bacteria and coated with alginate to form a GCS-LB biofilm, enhancing the colonization and survival ability of the bacteria, and monitoring microenvironment changes through DNA nano-device.

Benefits of technology

It significantly prolongs the retention time of lactic acid bacteria in the vagina, enhances its resistance to harsh environments, improves the therapeutic effect, and dynamically monitors pH changes and probiotic activity in the vagina through DNA nano devices, improving the predictability of treatment and effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909831A_ABST
    Figure CN118909831A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of new biomedical materials, and particularly discloses a preparation method and application of a lactic acid bacteria biological membrane based on gel cell growth, and the method comprises the following steps: 1) culturing vaginal epithelial cells until the cells grow into a complete cell sheet layer; 2) mixing a photoinitiator with polyethylene glycol diacrylate to prepare a gelation buffer solution, and adding the gelation buffer solution into a cell sheet layer for incubation; 3) washing with PBS, and irradiating with an ultraviolet lamp to initiate a polymerization reaction to form a colloidal cell sheet GCS; 4) incubating the GCS and floating lactic acid bacteria PLA, removing uncombined lactic acid bacteria, and adding an MRS culture medium for culturing to form a biological membrane; and 5) dripping calcium chloride on the biological membrane, coating the surface of the biological membrane with an alginate solution, and removing redundant alginate to obtain a final product, namely the gel cell growth-based lactic acid bacteria biological membrane GCS-LB. The traditional Chinese medicine composition has a good treatment effect on aerobic vaginitis.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of new biomedical materials, and specifically discloses a method for preparing a lactic acid bacteria biofilm based on gel cell growth and an application thereof. Background Art

[0002] Aerobic vaginitis (AV) is a vaginal infection characterized by mucosal congestion, pain, inflammation, increased aerobic bacteria, and decreased lactobacilli, which increase the risk of sexually transmitted diseases (e.g., HIV) and preterm birth. In clinical routine, empirical antibiotics are the main treatment for aerobic vaginitis; however, antibiotics indiscriminately kill pathogenic and beneficial strains in the vagina, leading to an imbalance in vaginal flora and a high recurrence rate. In addition, overuse of antibiotics may lead to the development of multidrug-resistant pathogens, further compromising treatment efficacy.

[0003] Lactobacillus plays a key role in maintaining vaginal homeostasis and health through multiple mechanisms, including competitive exclusion of pathogens, secretion of antimicrobial substances (e.g., lactic acid, H2O2, and antimicrobial peptides, etc.), and regulation of the host immune system. Therefore, the delivery of live lactic acid bacteria to the diseased vagina has become an acceptable means to combat AV and regulate the vaginal microenvironment. Although probiotic monotherapy has some effects, its therapeutic efficiency remains low because most probiotics are rapidly cleared or lose activity before successfully colonizing and surviving in the exclusive vaginal environment. In order to achieve a lasting effect, multiple doses of lactic acid bacteria must be given to improve cell colonization, but this greatly increases the cost of treatment and reduces patient compliance. Recently, some attractive engineering probiotic strategies have been developed to protect them from harsh conditions and enhance their colonization ability, which shows great promise in biomedical applications. However, most of these approaches are designed for the treatment of intestinal diseases, and few studies have been conducted on maintaining female reproductive health. In addition, dynamic evaluation of probiotic activity remains a huge challenge, resulting in unpredictable therapeutic outcomes in practical applications. Therefore, there is an urgent need to develop new therapeutic probiotic preparations for the diagnosis and treatment of vaginitis. Summary of the invention

[0004] In order to solve the above problems, the present invention provides a method for preparing a lactic acid bacteria biofilm based on gel cell growth and its application.

[0005] The present invention includes the following technical solutions:

[0006] A method for preparing a lactic acid bacteria biofilm based on gel cell growth comprises the following steps:

[0007] 1) Cultivating vaginal epithelial cells until they grow into complete cell sheets;

[0008] 2) mixing a photoinitiator with polyethylene glycol diacrylate to prepare a gelling buffer, and adding the buffer to the cell sheet for incubation;

[0009] 3) After washing with PBS, ultraviolet light is used to induce polymerization reaction to form a colloidal cell sheet GCS;

[0010] 4) incubating the GCS with the planktonic lactic acid bacteria PLA, removing the unbound lactic acid bacteria, and then adding MRS medium to form a biofilm;

[0011] 5) dropping calcium chloride on the biofilm, coating the biofilm surface with alginate solution, removing excess alginate, and obtaining the final product, a lactic acid bacteria biofilm GCS-LB based on gel cell growth.

[0012] Preferably, in the above-mentioned method for preparing a lactic acid bacteria biofilm based on gel cell growth, the photoinitiator in step 2) is 2-hydroxy-4'-(2-hydroxyethoxy)-2-methylacetophenone, and the final concentration of the photoinitiator in the gelation buffer is 1.2-1.5 g / mL; the concentration of polyethylene glycol diacrylate in the gel solution in step 2) is 5-10wt%, and the molecular weight range is 500-1000Da; the incubation time of the gel solution and the vaginal cell sheet is 5-10min.

[0013] Preferably, in the above-mentioned method for preparing a lactic acid bacteria biofilm based on gel cell growth, the wavelength of the ultraviolet lamp in step 3) is 365nm, the irradiation time is 5-10min, and the power of the ultraviolet lamp is 10-50W.

[0014] Preferably, in the above-mentioned method for preparing a lactic acid bacteria biofilm based on gel cell growth, in the step 4), the OD of the added lactic acid bacteria is 600 is 1; the planktonic lactic acid bacteria and the gel cell sheet are incubated for 2 hours, and after washing away the free lactic acid bacteria, the incubation is continued for 48 to 72 hours.

[0015] Preferably, in the above-mentioned method for preparing a lactic acid bacteria biofilm based on gel cell growth, in step 5), the final concentration of calcium chloride is 20 mM; and the incubation time of calcium chloride and biofilm is 10 min.

[0016] The invention also discloses a lactic acid bacteria biofilm GCS-LB based on gel cell growth, which is prepared by the above method.

[0017] The invention also discloses the use of the preparation method and the lactic acid bacteria biofilm GCS-LB in preparing medicine or medical equipment for treating aerobic vaginitis.

[0018] Furthermore, the present invention discloses a method for preparing a DNA-modified vaginal epithelial cell gelled cell sheet-supported lactic acid bacteria biofilm DNA-GCS-LB, comprising the following steps:

[0019] 1) synthesize an acid-sensitive DNA double strand, including an i-motif strand (IS) and a signal strand (SS); then, mix the two strands and incubate them, add GCS-LB for incubation, add reaction buffer, wash twice to remove excess DNA, obtain DNA-GCS-LB, and store the DNA-GCS-LB at low temperature for subsequent use; preferably, the i-motif strand (IS): 5'-cholesterol-TTTTTTTCCCTAACCCTAACCCTAACCC-quencher group (BHQ3)-3', the signal strand (SS): 5'-Cy5 (fluorescent group)-GGGTTAGGGTTAGGGTT / Cy7 (fluorescent group) / TTTTT-(cholesterol)-3'; the final concentration of the DNA is 2uM, and the incubation time with GCS-LB is 1h; the reaction buffer composition is 1×PBS, 2mM MgCl2 solution.

[0020] The invention also discloses a DNA-modified vaginal epithelial cell gelled cell sheet supported lactic acid bacteria biofilm DNA-GCS-LB, which is prepared by the above method.

[0021] The invention also discloses the use of the lactic acid bacteria biofilm DNA-GCS-LB in preparing medicines or medical devices for diagnosing or treating aerobic vaginitis.

[0022] In some embodiments, we evaluated the colonization of lactobacilli in the mouse vagina using an in vivo imaging system. 7 CFUs), GCS or GCS-LB (1×106 CFU), and fluorescence measurements were performed at different time points. Figure 4 As shown, a significantly weakened fluorescence signal was observed after mice were treated with PLA 4 hours after injection. These results indicate that ordinary PLA can be quickly excreted from the body and the signal completely disappeared at 48 hours, which means that a single inoculation is not enough to successfully colonize Lactobacillus. In contrast, the retention time of GCS-LB in the vagina was significantly prolonged and was still visible even 96 hours after injection. It is also worth noting that the fluorescence of Lactobacillus even increased within the first 8 hours, which may be due to the rapid proliferation of bacteria. The in vivo imager is Shanghai Tianneng Tanon ABL X6.

[0023] In some embodiments, we disclose the therapeutic application of DNA-GCS-LB in a mouse AV model: mice were intraperitoneally injected with β-estradiol every two days for 6 consecutive days. On the 7th day, 20 μl of E. coli was injected into the vagina once a day for 5 consecutive days, and then fed normally. After the mouse AV model was successfully established, PBS, PLA, and GCS-LB were injected into the vagina of the mice. On the 7th day, the vagina was repeatedly rinsed with sterile PBS (20 μL), and the liquid was pipetted 5 times to obtain vaginal secretions for quantitative analysis of E. coli and Lactobacillus cell viability on agar plates, as shown in Figure 2. Figure 5 As shown in Figure 2, the activity of lactic acid bacteria in the vagina of mice injected with GCS-LB was the highest. The final concentration of β-estradiol was 1 mg / mL; the concentration of Escherichia coli injected into the vagina of the constructed AV was 1×10 9 CFU / mL; the concentrations of PLA and GCS-LB injected intravaginally were 1×10 7 CFUs, 1×10 6 CFUs, the intravaginal injection PBS concentration was 1×PBS.

[0024] In some embodiments, we disclose the application of DNA-GCS-LB in the detection of pH in the mouse vaginal microenvironment (activity of lactobacilli): Since the DNA nanodevice can generate fluorescent signals in an acidic environment, the pH change in the biofilm can be dynamically monitored by using the pH-sensing DNA nanodevice through in vivo imaging observation. PBS, GCS-LB (1×10 6 CFUs), DNA-GCS-LB (1×10 6 CFUs), or DNA-GCS-iLB (1×10 6 CFUs) at different time points or measured by in vivo imaging system. Figure 6 As shown, DNA-GCS-LB in a healthy vagina can be easily distinguished using Cy7 fluorescence, and the Cy5 signal reaches a maximum value 4 hours after injection, indicating that lactobacilli produce lactic acid in the mouse vagina. The volume of the DNA-GCS-LB injected into the vagina is 20uL; the lactic acid bacteria biofilm in the DNA-GCS-LB is live bacteria, and the lactic acid bacteria biofilm in the DNA-GCS-iLB is inactivated by high temperature.

[0025] The present invention has the following beneficial effects:

[0026] The present invention discloses a method for preparing a lactic acid bacteria biofilm based on gel cell growth and its application. The principle is that lactic acid bacteria can naturally adhere to vaginal epithelial cells, which is an ideal substrate for probiotic adhesion and colonization, providing sufficient nutrition (i.e., glycogen) to maintain the activity and proliferation of lactic acid bacteria. Figure 1As shown. First, vaginal epithelial cells were cultured on a plate to grow into a complete sheet structure. This process not only retained the main characteristics of epithelial cells, but also greatly improved the stability of the cells due to the formation of intracellular hydrogels, making it suitable for in vitro and in vivo applications. Then, lactic acid bacteria were inoculated on the cell sheet of the gel and thoroughly washed to remove excess bacteria. After 48 hours of culture in MRS broth medium, a thick probiotic biofilm was formed on the cell sheet. The bacteria in the biofilm produce various soluble microbial products (SMPs) and extracellular polymer substances (EPSs) to protect them from higher survival rates in harsh environments; on this basis, a DNA nanodevice was further introduced into the GCS system, which includes an i-motif chain (IS) and a signal chain (SS). The system is used to monitor the activity of probiotics or changes in the microenvironment in real time. When lactic acid bacteria dominate the vaginal flora, as the pH value decreases, the IS rapidly folds into a compact i-motif structure, resulting in double dehybridization and the recovery of Cy5 fluorescence. The “always-on” Cy7 fluorophore, which is insensitive to pH changes, produces a stable fluorescent signal that can directly locate biofilms in vivo, thereby achieving dynamic detection of changes in pH levels within the vagina.

[0027] Compared with the prior art, the present invention has at least the following beneficial effects:

[0028] Due to the presence of gelled cell sheets, lactic acid bacteria with relatively poor biofilm-forming ability can still form thicker biofilms and protect them from different adverse conditions. Compared with planktonic lactic acid bacteria (PLA), GCS-LB / DNA-GCS-LB has several attractive features:

[0029] 1. Enhanced resistance to different pressures;

[0030] 2. Prolong the vaginal retention time of mice;

[0031] 3. The developed DNA nanodevice can dynamically and remotely monitor the activity of probiotics in vivo without the need for cumbersome secretion collection and pH testing steps;

[0032] 4. Better treatment effect on AV. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 Schematic diagram of the preparation and application of GCS-LB, (a) Schematic diagram of the preparation of GCS-LB and its application in (b) microenvironment monitoring and (c) aerobic vaginitis treatment;

[0034] Figure 2Preparation and characterization of GCS-LB, (a) Non-gelled or gelled cell sheets (NCS, GCS) after different treatments, including pure water (PW), lactobacillus culture medium (LCM) and long-term storage (LTS) (30 days) in PBS; (b) SEM images of GCS after 2 hours of PLA culture and lactobacillus biofilm on GCS after 48 hours of culture, blue arrows show lactobacilli adsorbed on GCS, and red arrows show the network structure of extracellular polymers in the biofilm;

[0035] Figure 3 Schematic diagram of the response of the DNA nanodevice modified on the gelled cell membrane to pH changes;

[0036] Figure 4 In vivo imaging system was used to evaluate the colonization of lactobacilli in the mouse vagina. (a) Mice were given PLA (1×10 7 CFU) or GCS-LB (1×10 6 (b) The retention rates of PLA and GCS-LB in the mouse vagina at different time points;

[0037] Figure 5 :Evaluation of lactic acid bacteria activity in mouse vagina, injection of PLA (1×10 7 CFU) and GCS-LB (1×10 6 CFU) of Lactobacillus colonies collected from vaginal secretions of mice 48 hours later. Mice without any treatment were used as negative controls;

[0038] Figure 6 :DNA nanodevice dynamically monitors pH changes in the vagina. Mice were vaginally administered PBS, GCS-LB (1×10 6 CFU), DNA-GCS-LB (1×10 6 CFU) and DNA-GCS-iLB (1x 10 6 CFUs) were measured by an in vivo imaging system. DETAILED DESCRIPTION

[0039] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0040] The reagents or instruments used in the examples of the present invention without indicating the manufacturer are all conventional reagent products that can be obtained through commercial purchase.

[0041] Example 1

[0042] A method for preparing a lactic acid bacteria biofilm based on gel cell growth comprises the following steps:

[0043] VK2 cells were seeded in a 6-well plate until a complete cell sheet was formed. 2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone was mixed with a gel monomer, polyethylene glycol diacrylate, to prepare a gel solution. Then, the prepared gel buffer was added to the cell plate for incubation, the cell plate was thoroughly washed with DMEM, and the cells were irradiated with UV light to form a gelled cell sheet. Then, the planktonic lactic acid bacteria solution was added to the gel cell sheet (GCS) plate for incubation. After removing the unbound bacteria, fresh MRS culture medium was added to the cell wells for culture. The cell plate was then carefully washed to remove free bacteria, calcium chloride was dropped on the biofilm, and then the biofilm surface was coated with alginate solution to remove excess alginate. The final product (i.e., GCS-LB) was collected using a cell scraper and redispersed in a PBS solution for subsequent use. Finally, the stability of the colloidal cell sheet was verified using pure water, lactic acid bacteria culture medium, and long-term storage (30 days), with ordinary cell sheets as controls. Normal cell sheets (NCSs) quickly broke and detached from the plate surface, while GCSs retained their intact structure without obvious changes. Figure 2 As shown, it provides a stable platform for bacterial adhesion, proliferation and biofilm formation. The concentration of polyethylene glycol diacrylate in the gel solution is 5-10wt%, and the molecular weight range is 500-1000Da; the final concentration of the photoinitiator 2-hydroxy-4'-(2-hydroxyethoxy)-2-methylacetophenone is 1.2-1.5g / mL, and the gel solution and magnetized cells are incubated for 5-10 minutes; the 365nm ultraviolet lamp irradiates the cell suspension for 5-10 minutes, and the ultraviolet lamp power is 10-50W. The added lactic acid bacteria OD 600 is 1; the incubation time of the planktonic lactic acid bacteria and the gel cell sheet is 2 hours, and after washing away the free bacteria, the incubation is continued for 48 to 72 hours; the final concentration of calcium chloride is 20 mM; the incubation time of calcium chloride and the biofilm is 10 minutes.

[0044] Example 2

[0045] A method for preparing DNA-GCS-LB, a lactic acid bacteria biofilm supported by a DNA-modified vaginal epithelial cell gelled cell sheet, comprises the following steps:

[0046] To achieve this goal, we designed an acid-sensitive DNA duplex, such as Figure 3As shown, it includes an i-motif chain (IS) and a signal chain (SS). Specifically, SS has a cholesterol moiety at the 3' end, a Cy5 fluorophore (Ex / Em=650 / 670nm) at the 5' end, and a Cy7 fluorophore (Ex / Em=750 / 780nm) at the middle nucleotide. IS is labeled with a cholesterol moiety at the 5' end and a quencher (BHQ3) at the 3' end. The DNA is a primer synthesized by Sangon Biotech Co., Ltd.; the primer chain sequence is: SEQ ID No.1 = i-motif chain (IS): 5'-cholesterol-TTTTTTTCCCTAACCCTAACCCTAACCC-quencher (BHQ3)-3', SEQ ID No.2 = signal chain (SS): 5'-Cy5 (fluorophore)-GGGTTAGGGTTAGGGTT / Cy7 (fluorophore) / TTTTT-(cholesterol)-3'. The two DNA chains were mixed and incubated, and GCS-LB was added for incubation. Due to the fluorescence resonance energy transfer (FRET) effect, the proximity between Cy5 and BHQ3 resulted in effective fluorescence quenching. Then, the excess DNA was removed by washing twice, and the DNA-GCS-LB was stored at 4°C for subsequent use. The incubation time of the DNA chain and GCS-LB was 1 hour; the reaction buffer components were 1×PBS, 2mM MgCL2 solution.

[0047] Test Example 1

[0048] We evaluated the colonization of lactobacilli in the mouse vagina using an in vivo imaging system. PLA (1×10 7 CFUs), GCS or GCS-LB (1×10 6 CFU) were added to 1 μg / mL Cy7 dye and incubated in the dark for 30 minutes. After centrifugation, they were injected into the vagina of mice and fluorescence was measured at different time points. Figure 4 As shown, a significantly weakened fluorescence signal was observed after mice were treated with PLA 4 hours after injection. These results indicate that ordinary PLA can be rapidly excreted from the body and the signal completely disappeared at 48 hours, meaning that a single inoculation is not sufficient to successfully colonize Lactobacillus. In contrast, GCS-LB retained a significantly longer retention time in the vagina and was still visible even 96 hours after injection. It is also noteworthy that the fluorescence of Lactobacillus increased even within the first 8 hours, which may be due to the rapid proliferation of bacteria.

[0049] Test Example 2

[0050] Therapeutic application of DNA-GCS-LB in mouse AV model: Mice were intraperitoneally injected with β-estradiol every two days for 6 consecutive days. On the 7th day, 20 μl of E. coli was injected into the vagina once a day for 5 consecutive days, and then fed normally. After the mouse AV model was successfully established, the mice were injected with PBS, PLA, and GCS-LB intravaginally. On the 7th day, the vagina was repeatedly rinsed with sterile PBS (20 μL) and pipetted 5 times to obtain vaginal secretions for quantitative analysis of E. coli and Lactobacillus cell viability on agar plates, as shown in Figure 2. Figure 5 As shown in Figure 2, the activity of lactic acid bacteria in the vagina of mice injected with GCS-LB was the highest. The final concentration of β-estradiol was 1 mg / mL; the concentration of Escherichia coli injected into the vagina of the constructed AV was 1×10 9 CFU / mL; the concentrations of PLA and GCS-LB injected intravaginally were 1×10 7 CFUs, 1×10 6 CFUs, the intravaginal injection PBS concentration was 1×PBS.

[0051] Test Example 3

[0052] Application of DNA-GCS-LB in pH detection of mouse vaginal microenvironment (activity of lactobacilli): Since DNA nanodevices can generate fluorescent signals in acidic environments, pH changes in biofilms can be dynamically monitored by using pH-sensing DNA nanodevices through in vivo imaging observation. PBS and GCS-LB (1×10 6 CFUs), DNA-GCS-LB (1×10 6 CFUs), or DNA-GCS-iLB (1×10 6 CFUs) at different time points or measured by in vivo imaging system. Figure 6 As shown, DNA-GCS-LB in a healthy vagina can be easily distinguished using Cy7 fluorescence, and the Cy5 signal reaches a maximum value 4 hours after injection, indicating that lactobacilli produce lactic acid in the mouse vagina; the lactic acid bacteria biofilm in the DNA-GCS-LB is live bacteria, and the lactic acid bacteria biofilm in the DNA-GCS-iLB is inactivated by high temperature.

[0053] As can be seen from the above examples, we culture vaginal epithelial cells on a flat plate to grow into a complete sheet structure. This process not only retains the main characteristics of epithelial cells, but also greatly improves the stability of the cells due to the formation of intracellular hydrogels, making it suitable for in vitro and in vivo applications. Then, lactic acid bacteria are inoculated on the cell sheet of the gel and thoroughly washed to remove excess bacteria. After culturing in MRS broth medium for 48 hours, a thick probiotic biofilm is formed on the cell sheet. The bacteria in the biofilm produce various soluble microbial products (SMPs) and extracellular polymer substances (EPSs) to protect them from higher survival rates in harsh environments. Finally, a DNA nanodevice is used to introduce the GCS system, which includes an i-motif chain (IS) and a signal chain (SS). The system is used to monitor the activity of probiotics or changes in the microenvironment in real time. When lactic acid bacteria in the vagina are the main dominant flora, as the pH value decreases, IS quickly folds into a compact i-motif structure, resulting in double dehybridization and recovery of Cy5 fluorescence. The “always-on” Cy7 fluorophore, which is insensitive to pH changes, produces a stable fluorescent signal that can directly locate biofilms in vivo, thereby achieving dynamic detection of changes in pH levels within the vagina.

[0054] The above embodiments show and describe the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the above embodiments do not limit the present invention in any form, and any technical solution obtained by equivalent replacement or equivalent transformation falls within the protection scope of the present invention.

Claims

1. A method for preparing a lactic acid bacteria biofilm based on gel cell growth, characterized in that: The following steps are involved: 1) Cultivating vaginal epithelial cells until they grow into complete cell sheets; 2) mixing a photoinitiator with polyethylene glycol diacrylate to prepare a gelling buffer, and adding the buffer to the cell sheet for incubation; 3) After washing with PBS, ultraviolet light is used to induce polymerization reaction to form a colloidal cell sheet GCS; 4) incubating the GCS with the planktonic lactic acid bacteria PLA, removing the unbound lactic acid bacteria, and then adding MRS medium to form a biofilm; 5) dropping calcium chloride on the biofilm, coating the biofilm surface with alginate solution, removing excess alginate, and obtaining the final product, a lactic acid bacteria biofilm GCS-LB based on gel cell growth.

2. The method for preparing a lactic acid bacteria biofilm based on gel cell growth according to claim 1, characterized in that: The photoinitiator in step 2) is 2-hydroxy-4'-(2-hydroxyethoxy)-2-methylacetophenone, and the final concentration of the photoinitiator in the gelation buffer is 1.2-1.5 g / mL; the concentration of polyethylene glycol diacrylate in the gel solution in step 2) is 5-10 wt%, and the molecular weight range is 500-1000 Da; the incubation time of the gel solution and the vaginal cell sheet is 5-10 min.

3. The method for preparing a lactic acid bacteria biofilm based on gel cell growth according to claim 1, characterized in that: In the step 3), the wavelength of the ultraviolet lamp is 365 nm, the irradiation time is 5 to 10 minutes, and the power of the ultraviolet lamp is 10 to 50 W.

4. The method for preparing a lactic acid bacteria biofilm based on gel cell growth according to claim 1, characterized in that: In the step 4), the added lactic acid bacteria OD 600 is 1; the planktonic lactic acid bacteria and the gel cell sheet are incubated for 2 hours, and after washing away the free lactic acid bacteria, the incubation is continued for 48 to 72 hours.

5. The method for preparing a lactic acid bacteria biofilm based on gel cell growth according to claim 1, characterized in that: In the step 5), the final concentration of calcium chloride is 20 mM; and the incubation time of calcium chloride and biofilm is 10 min.

6. A lactic acid bacteria biofilm GCS-LB based on gel cell growth, characterized in that: The method is prepared by any one of claims 1 to 5.

7. Use of the lactic acid bacteria biofilm GCS-LB as claimed in claim 6 in the preparation of a medicine or medical device for treating aerobic vaginitis.

8. A method for preparing DNA-modified vaginal epithelial cell gelled cell sheet-supported lactic acid bacteria biofilm DNA-GCS-LB, characterized in that: The following steps are involved: 1) synthesize an acid-sensitive DNA double strand, including an i-motif strand (IS) and a signal strand (SS); then, mix the two strands and incubate them, add GCS-LB for incubation, add reaction buffer, wash twice to remove excess DNA, obtain DNA-GCS-LB, and store the DNA-GCS-LB at low temperature for subsequent use; preferably, the i-motif strand (IS): 5'-cholesterol-TTTTTTTCCCTAACCCTAACCCTAACCC-quencher group (BHQ3)-3', the signal strand (SS): 5'-Cy5 (fluorescent group)-GGGTTAGGGTTAGGGTT / Cy7 (fluorescent group) / TTTTT-(cholesterol)-3'; the final concentration of the DNA is 2uM, and the incubation time with GCS-LB is 1h; the reaction buffer composition is 1×PBS, 2mM MgCl2 solution.

9. A DNA-modified vaginal epithelial cell gelled cell sheet supported lactic acid bacteria biofilm DNA-GCS-LB, characterized in that: Prepared by the method described in claim 8.

10. Use of the lactic acid bacteria biofilm DNA-GCS-LB according to claim 9 in the preparation of a drug or medical device for diagnosing or treating aerobic vaginitis.